Roche’s Antibody Cocktail launched in India at Rs 59,750/dose; Cipla to market drug in country

What does the antibody cocktail approved by India contain and how does it work?

Covid-19: Roche receives Emergency Use Authorisation in India for its investigational antibody Cocktail jab

Cancer drug: SC allows Cipla to withdraw appeal against Roche

Latest Additions

Indira Gandhi protected environment, which is under ‘systematic assault’ now: Ramesh

Ahead of Parliament session, govt convenes all-party meet on Sunday

Noida, Ghaziabad schools ordered to conduct classes online due to air pollution

Earthquake of 4 magnitude hits Kutch in Gujarat; no casualty or damage

Bihar: Seven police personnel held for consuming, selling seized liquor

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.